P

Inventor

MEASE RONNIE C

US34 patents
⚠️ This page may combine multiple inventors who share the name “MEASE RONNIE C”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

UNIV JOHNS HOPKINS

22 patents
US9776977B2Oct 3, 2017

PSMA-targeting compounds and uses thereof

UNIV JOHNS HOPKINS14 citations92
US9694091B2Jul 4, 2017

Labeled inhibitors of prostate specific membrane antigen (PSMA) biological evaluation, and use of imaging agents

UNIV JOHNS HOPKINS19 citations91
US9884132B2Feb 6, 2018

Homomultivalent and heteromultivalent inhibitors of prostate specific membrane antigen (PSMA) and uses thereof

UNIV JOHNS HOPKINS9 citations83
US10039845B2Aug 7, 2018

Labeled inhibitors of prostate specific membrane antigen (PSMA) biological evaluation, and use of imaging agents

UNIV JOHNS HOPKINS7 citations82
US9371360B2Jun 21, 2016

Homomultivalent and heteromultivalent inhibitors of prostate specific membrane antigen (PSMA) and uses thereof

UNIV JOHNS HOPKINS12 citations82
US11661402B2May 30, 2023

PSMA-targeting compounds and uses thereof

UNIV JOHNS HOPKINS3 citations73
US11021450B2Jun 1, 2021

PSMA targeted fluorescent agents for image guided surgery

UNIV JOHNS HOPKINS4 citations73
US10736974B2Aug 11, 2020

Scaffolds and multifunctional intermediates for imaging PSMA and cancer therapy

UNIV JOHNS HOPKINS4 citations73
US10717750B2Jul 21, 2020

68Ga-labeled NOTA-chelated PSMA-targeted imaging and therapeutic agents

UNIV JOHNS HOPKINS4 citations73
US10653806B2May 19, 2020

Homomultivalent and heteromultivalent inhibitors of prostate specific membrane antigen (PSMA) and uses thereof

UNIV JOHNS HOPKINS4 citations72
US11813340B2Nov 14, 2023

PSMA targeted radiohalogenated urea-polyaminocarboxylates for cancer radiotherapy

UNIV JOHNS HOPKINS2 citations71
US10683272B2Jun 16, 2020

Metal/radiometal-labeled PSMA inhibitors for PSMA-targeted imaging and radiotherapy

UNIV JOHNS HOPKINS5 citations71
US10369113B2Aug 6, 2019

Prostate specific membrane antigen (PSMA) targeted nanoparticles for therapy of prostate cancer

UNIV JOHNS HOPKINS4 citations71
US10947197B2Mar 16, 2021

Synthesis of the radiolabeled prostate-specific membrane antigen (PSMA) inhibitor [18F]DCFPyL

UNIV JOHNS HOPKINS3 citations70
US12065413B2Aug 20, 2024

PSMA targeted fluorescent agents for image guided surgery

UNIV JOHNS HOPKINS0 citations62
US11911488B2Feb 27, 2024

Scaffolds and multifunctional intermediates for imaging PSMA and cancer therapy

UNIV JOHNS HOPKINS0 citations62
US11814365B2Nov 14, 2023

PSMA targeted fluorescent agents for image guided surgery

UNIV JOHNS HOPKINS0 citations62
US11078166B2Aug 3, 2021

Triazole conjugated ureas, thioureas, carbamates, and reversed carbamates for PSMA-targeted imaging agents and uses thereof

UNIV JOHNS HOPKINS0 citations62
US12233137B1Feb 25, 2025

PSMA targeted radiohalogenated urea-polyaminocarboxylates for cancer radiotherapy

UNIV JOHNS HOPKINS0 citations60
US11851407B2Dec 26, 2023

Synthesis of the radiolabeled prostate-specific membrane antigen (PSMA) inhibitor [18F]DCFPYL

UNIV JOHNS HOPKINS0 citations59
US10156521B2Dec 18, 2018

Red fluorescent aldehyde dehydrogenase (ALDH) substrate

UNIV JOHNS HOPKINS0 citations47
US10857246B2Dec 8, 2020

Nuclear imaging and radiotherapeutics agents targeting carbonic anhydrase IX and uses thereof

UNIV JOHNS HOPKINS0 citations39

ASS UNIVERSITIES INC

6 patents

BROOKHAVEN SCIENCE ASS LLC

2 patents

POMPER MARTIN G

1 patent

(unassigned)

1 patent

CHANDRAN SACHIN S

1 patent

RES CORP TECHNOLOGIES INC

1 patent